Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pericardial synovial sarcoma: 14-year survival with multimodality therapy  Gerry Van der Mieren, MD, Stefan Willems, MD, Raf Sciot, MD, PhD, Herlinde Dumez,

Similar presentations


Presentation on theme: "Pericardial synovial sarcoma: 14-year survival with multimodality therapy  Gerry Van der Mieren, MD, Stefan Willems, MD, Raf Sciot, MD, PhD, Herlinde Dumez,"— Presentation transcript:

1 Pericardial synovial sarcoma: 14-year survival with multimodality therapy 
Gerry Van der Mieren, MD, Stefan Willems, MD, Raf Sciot, MD, PhD, Herlinde Dumez, MD, Allan Van Oosterom, MD, PhD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD  The Annals of Thoracic Surgery  Volume 78, Issue 3, Pages e41-e42 (September 2004) DOI: /j.athoracsur

2 Fig 1 Photomicrograph of a typical biphasic appearance of a biphasic synovial sarcoma. The plump epithelial cells have ovoid nuclei and form glandular structures and solid nests. The spindle cells have sparse cytoplasm, short fusiform, or small nuclei. They have indistinct cell borders and form intersecting fascicles between the glandular structures. (Hematoxylin and eosin, ×40.) The Annals of Thoracic Surgery  , e41-e42DOI: ( /j.athoracsur )

3 Fig 2 Magnetic resonance image from December 1996 shows the first tumor recurrence between the vena cava superior and the aorta. The Annals of Thoracic Surgery  , e41-e42DOI: ( /j.athoracsur )


Download ppt "Pericardial synovial sarcoma: 14-year survival with multimodality therapy  Gerry Van der Mieren, MD, Stefan Willems, MD, Raf Sciot, MD, PhD, Herlinde Dumez,"

Similar presentations


Ads by Google